OakChart

Clover Health Investments Corp

CLOVHealthcare·Healthcare Plans·USA·Mid·NASD·Nov 11 • 12:56 PM ET

5.03+0.10 (1.93%)
2026-11-11 18:56 CET
Market cap
2,618.59 USD m
Revenue, TTM
2,739.37 USD m
Net income, TTM
12.45 USD m
Free cash flow, TTM
132.28 USD m
EPS diluted, TTM
0.02
P/E
265.87
Compare

Price

CLOV against its 20, 50 and 200-day averages
2050200beat
2.003.004.005.0013.1M26.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CLOVclose 5.0320-day 4.6550-day 4.58200-day 3.635.0352w high

10.1% under the 52-week high of 5.59 on 29 Jun 2026. 52-week low 1.58 on 1 Apr 2026. Last 15 sessions, 25.9% high to low

Profile

CLOV
52-week range, 86% of the way up
1.585.59

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

IndexRUT
Employees724
IPOJun 12, 2020
Beta2.46
ATR, 14d0.29
Rel volume0.74
Short float5.61%
Insider own22.72%
Inst own27.42%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.67B
Enterprise Value-
Income12.45M
Sales2.74B
Book/sh0.79
Cash/sh-
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees724
IPOJun 12, 2020

Ratios

P/E265.87
Forward P/E41.76
PEG0.57
P/S0.97
P/B6.40
P/C-
P/FCF20.18
EV/EBITDA-
EV/Sales-
Quick Ratio-
Current Ratio1.55
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)0.02
EPS next Y0.12
EPS next Q-0.05
EPS this Y66.75%
EPS next Y99.66%
EPS next 5Y73.48%
EPS past 3/5Y38.35% 35.85%
Sales past 3/5Y-17.97% 22.90%
EPS Y/Y TTM119.43%
Sales Y/Y TTM54.46%
EPS Q/Q124.21%
Sales Q/Q52.89%
EarningsNov 04 AMC
EPS/Sales Surpr.296.08% 2.60%

Ownership

Insider Own22.72%
Insider Trans-1.50%
Inst Own27.42%
Inst Trans6.48%
ROA1.90%
ROE3.40%
ROIC3.19%
Gross Margin-
Oper. Margin0.45%
Profit Margin0.45%
SMA208.18%
SMA509.65%
SMA20038.59%
Trades-

Technical

Shs Outstand531.15M
Shs Float410.46M
Short Float5.61%
Short Ratio5.40
Short Interest23.03M
52W High5.59 -10.11%
52W Low1.58 218.04%
Volatility9.94% 5.91%
ATR (14)0.29
RSI (14)60.85
Beta2.46
Rel Volume0.74
Avg Volume4.26M
Volume1,731,431

Performance

Perf Week7.14%
Perf Month4.47%
Perf Quarter11.92%
Perf Half Y41.55%
Perf YTD113.83%
Perf Year97.06%
Perf 3Y456.42%
Perf 5Y-29.72%
Perf 10Y-
Recom1.80
Target Price5.60
Prev Close4.93
Price5.03
Change %1.93%

Analyst ratings

latest 10 of 17
DateActionAnalystRating changeTargetImplied
Oct 28, 2026InitiatedNNeedhamBuy$6+19.4%
Sep 10, 2026InitiatedDDeutsche BankBuy$6+19.4%
Dec 17, 2024InitiatedCCraig HallumBuy$6+19.4%
Oct 07, 2024InitiatedUUBSNeutral$4-20.4%
Feb 02, 2022UpgradeCCowenUnderperform → Market Perform$7 → $3-40.3%
Feb 02, 2022InitiatedCCanaccord GenuityBuy$6+19.4%
Jan 19, 2022InitiatedSSVB LeerinkMkt Perform$3-40.3%
Jan 10, 2022ResumedCCitigroupNeutral$9 → $3.50-30.3%
Jan 07, 2022DowngradeCCredit SuisseNeutral → Underperform$9 → $3.50-30.3%
Sep 10, 2021InitiatedCCowenUnderperform$7+39.3%

Peers

Mkt cap
TickerCompanyMkt cap
ALHCAlignment Healthcare Inc1.62B
HUMHumana Inc53.52B
OSCROscar Health Inc9.96B
UNHUnitedhealth Group Inc357.60B
CVSCVS Health Corp113.53B
ELVElevance Health Inc91.92B
MOHMolina Healthcare Inc10.88B
ASTHAstrana Health Inc1.63B
CNCCentene Corp34.90B
AGLAgilon Health Inc1.93B

Insider trading

latest 14 of 89
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Soares KarenChief Legal OfficerOct 20 '26Sale4.6619,27589,8221,573,423Oct 20 05:56 PM
Reynoso Jamie L.CEO, Medicare AdvantageOct 19 '26Sale4.414,06617,9312,770,351Oct 20 04:43 PM
KAREN SOARESOfficerOct 20 '26Proposed Sale4.4419,27585,581Oct 20 04:25 PM
Toy AndrewChief Executive OfficerOct 15 '26Sale4.6862,176290,9849,078,334Oct 19 04:31 PM
JAMIE REYNOSOOfficerOct 19 '26Proposed Sale4.484,06618,216Oct 19 04:27 PM
Soares KarenChief Legal OfficerOct 15 '26Sale4.6814,67368,6701,592,698Oct 19 04:26 PM
THORNTON JOSEPH CLAYInterim CFOOct 15 '26Sale4.684,59121,4861,244,935Oct 19 04:23 PM
Wai ConradCEO, Counterpart HealthOct 15 '26Sale4.6823,627110,5741,042,072Oct 19 04:22 PM
Reynoso Jamie L.CEO, Medicare AdvantageOct 15 '26Sale4.6818,27385,5182,774,417Oct 19 04:19 PM
Andrew ToyOfficerOct 15 '26Proposed Sale4.6860,765284,380Oct 15 06:55 PM
Joseph Clay ThorntonOfficerOct 15 '26Proposed Sale4.684,48720,999Oct 15 06:54 PM
Conrad WaiOfficerOct 15 '26Proposed Sale4.6823,463109,807Oct 15 06:53 PM
Karen M. SoaresOfficerOct 15 '26Proposed Sale4.6814,34167,116Oct 15 06:50 PM
Jamie ReynosoOfficerOct 15 '26Proposed Sale4.6817,85883,575Oct 15 06:48 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 206
  • Clover Health Beats On A Thin GAAP Profit As A 5-Star PPO Rating And Strong Early AEP Shift The Debate To 2027 (Earnings Whispers) +9.32%
  • Clover Health Reports Third Quarter 2026 Results (GlobeNewswire)
  • Clover Health climbs after Needham initiates coverage with Buy, $6 target (Investing.com)
  • Clover Health's Q3 Test: Can Cost Trends Hold As Guidance Implies A Second-Half Slowdown? (Earnings Whispers)
  • Clover Health to Participate in Upcoming UBS Global Healthcare Conference (GlobeNewswire)
  • Loading…
  • Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States (GlobeNewswire) +8.11%
  • Is Clover Health Stock Too Dependent On One Group Of Members? (Trefis)
  • Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027 (GlobeNewswire)
  • Humana Soars On Medicare Advantage Star Rating (Investor's Business Daily)
  • Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
  • Clover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value (GlobeNewswire)
  • UPDATE - Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors (GlobeNewswire)
  • Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.010-0.0050.010759.3740.075
2026Q22026-08-050.0500.0390.051743.17728.273
2026Q12026-05-060.0730.0690.051749.19714.892
2025Q42026-02-26-0.051-0.102-0.095487.71467.063
2025Q32025-11-04-0.050-0.030-0.048496.65471.083
2025Q22025-08-05-0.020-0.009-0.021477.62468.34
2025Q12025-05-060.054-0.041-0.003462.33466.934
2024Q42025-02-27-0.040-0.066-0.045336.96347.414
2024Q32024-11-06-0.020-0.041-0.019330.99346.283
2024Q22024-08-050.010-0.0490.015356.26338.763
2024Q12024-05-07-0.050-0.072-0.039346.92321.233
2023Q42024-03-12-0.146-0.139-0.146510.25474.013
2023Q32023-11-06-0.086-0.106-0.086482.07494.593
2023Q22023-08-08-0.060-0.139-0.060513.63490.826
2023Q12023-05-09-0.152-0.167-0.152527.78498.736
2022Q42023-02-28-0.176-0.239-0.176898.79785.486

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-0.227-1.287-1.538672.89673.79
2021FY-1.307-1.153-1.4231,4721,450
2022FY-0.712-0.732-0.7133,4773,367
2023FY-0.443-0.416-0.4432,0341,997
2024FY-0.090-0.119-0.0881,3711,382
2025FY0.036-0.173-0.1701,9241,904
2026FY-0.060--2,987
2027FY-0.120--3,664
2028FY-0.189--4,278
2029FY-0.258--4,477
2030FY-0.310--5,141

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05430734.4728.1742.5
2026Q4S2026-11-04400723.46718.59729.83
2026Q4S2026-10-27400723.46718.59729.83
2026Q4S2026-10-20300723.47718.59729.83
2026Q4S2026-08-10320723.47718.59729.83
2026Q4S2026-08-06320723.47718.59729.83
2026Q4S2026-07-26300709.93702.2713.81
2026Q4S2026-07-21301709.93702.2713.81
2026Q4S2026-07-20311709.93702.2713.81
2026Q4S2026-05-12311709.93702.2713.81
2026Q4S2026-05-07320712.99711.4713.81
2026Q4S2026-03-31330708.85695.77719.4
2026Q4S2026-03-18330708.85695.77719.4
2026Q4S2026-03-03330705.39695.77711.4

Estimate history

EPS, annual0-1.538-1.423-0.713-0.443-0.088-0.1670.0189
Period2019202020212022202320242025TTM
EPS, quarterly-0.019-0.045-0.003-0.021-0.048-0.0950.0510.0510.012
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0686.3111538.1423486.8041255.7311370.6141924.2882739.37
Period2019202020212022202320242025TTM
Sales, quarterly330.986336.93462.331477.601496.65487.706749.189743.167759.304
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual103.589.206470.838476.321481.139484.772485.63497.629
Period2019202020212022202320242025MRQ
Shares, quarterly483.472484.772480.881482.629483.93485.63490.294493.365497.629
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue2,739.371,924.291,370.611,255.733,486.801,538.14686.310.00
Losses, Claims & Reserves2,222.771,568.411,006.33997.353,360.431,661.81572.950.00
Selling, General and Administrative Incl. Other504.15441.43410.26442.75487.90447.18192.640.02
Operating Income before Interest Expense12.45-85.55-45.98-184.38-361.53-570.85-79.28-0.02
Interest Expense0.000.000.000.011.3616.9157.110.00
Unusual Expense-0.000.2925.77-23.33---
Net Income Before Taxes12.45-85.55-46.27-210.15-339.57-587.76-136.39-0.02
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income12.45-85.55-46.27-210.15-339.57-587.76-136.39-0.02
Net Income From Continuing Operations12.45-85.55-46.27-210.15-339.57-587.76-136.39-0.02
Net Income12.45-85.55-43.01-213.36-339.57-587.76-136.39-0.02
EPS (Recurring)0.02-0.17-0.09-0.41-0.75-1.42-1.54-0.00
EPS (Basic, Before Extraordinaries)0.02-0.17-0.09-0.44-0.71-1.42-1.54-0.00
EPS (Diluted)0.02-0.17-0.09-0.44-0.71-1.42-1.54-0.00
Non-Operating Income (Expense)0.000.000.000.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense49.06103.66114.33140.93164.31119.525.17-
Price To Earnings Ratio260.85260.85------
Price To Sales Ratio0.880.631.130.370.131.002.17-
Operating Margin0.45-4.45-3.35-14.68-10.37-37.11-11.55-
Net Margin0.45-4.45-3.14-16.99-9.74-38.21-19.87-
Shares Outstanding497.63485.63484.77481.14476.32470.8489.21103.50
Market Capitalization2,618.592,618.591,578.49464.29444.251,591.551,735.691,656.00
Operating Income after Interest Expense--85.55-45.98-184.38-362.89-587.76-136.39-0.02
Reserves Increase (Decrease)-0.000.000.000.000.000.000.00

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue759.30743.17749.19487.71496.65477.60462.33336.93
Losses, Claims & Reserves629.46590.16589.65413.50423.47377.99353.44243.04
Selling, General and Administrative Incl. Other123.41125.00132.21123.5397.55110.19110.16115.37
Operating Income before Interest Expense6.4328.0027.33-49.32-24.38-10.58-1.27-21.48
Interest Expense0.000.000.000.000.00-0.000.00
Operating Income after Interest Expense6.4328.0027.33-49.32-24.38--1.27-21.48
Unusual Expense---0.000.000.000.000.00
Net Income Before Taxes6.4328.0027.33-49.32-24.38-10.58-1.27-21.48
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income6.4328.0027.33-49.32-24.38-10.58-1.27-21.48
Net Income From Continuing Operations6.4328.0027.33-49.32-24.38-10.58-1.27-21.48
Net Income6.4328.0027.33-49.32-24.38-10.58-1.27-22.09
EPS (Recurring)0.010.050.05-0.10-0.05-0.02-0.00-0.04
EPS (Basic, Before Extraordinaries)0.010.050.05-0.10-0.05-0.02-0.00-0.04
EPS (Diluted)0.010.050.05-0.10-0.05-0.02-0.00-0.04
Non-Operating Income (Expense)0.000.000.000.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.028.9012.4519.6926.1126.2026.4429.64
Price To Earnings Ratio260.85-------
Price To Sales Ratio0.881.150.420.630.880.881.201.13
Operating Margin0.853.773.65-10.11-4.91-2.21-0.28-6.38
Net Margin0.853.773.65-10.11-4.91-2.21-0.28-6.56
Shares Outstanding497.63493.36490.29485.63483.93482.63480.88484.77
Market Capitalization2,618.592,759.83923.411,214.191,568.291,419.881,834.161,578.49

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Cash78.30194.54116.41103.79299.9792.350.00
Investments241.62243.07240.82369.08491.2358.760.00
Premium Balance Receivables - Insurance158.7492.7986.2490.9982.9773.570.00
Net Property, Plant & Equipment6.385.315.089.787.659.960.00
Investment in Unconsolidated Affiliates0.000.000.000.000.000.000.00
Other Intangible Assets55.9745.03122.12234.9868.9932.620.10
Total Assets541.01580.74570.67808.62950.80267.250.10
Insurance Policy Liabilities - Insurance153.25156.40137.10149.19249.23102.430.00
Total Debt0.000.000.005.8627.83138.360.00
Long Term Debt0.000.000.004.0324.77112.760.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities79.0683.20147.18296.69134.43191.910.12
Total Liabilities232.31239.60284.28451.73411.49432.700.12
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00447.750.00
Common Equity308.70341.14286.39356.89535.41-617.10-0.02
Total Shareholders Equity308.70341.14286.39356.89535.41-169.35-0.02
Accumulated Minority Interest0.000.000.000.003.903.900.00
Total Equity308.70341.14286.39356.89539.32-165.45-0.02
Total Liabilities & Stockholders Equity541.01580.74570.67808.62950.80267.250.10
Book Value Per Share0.640.700.600.751.14-6.92-0.00
Tangible Book Value Per Share0.630.700.590.711.13-6.97-0.00
Full-Time Employees724570552656680458-
Price to Book Ratio6.284.481.421.133.272.192.08
Return on Assets-15.25-8.04-30.47-38.60-65.05-102.03-
Return on Equity-26.33-14.75-65.34-76.11-88.46-1.70-
Return on Invested Capital-27.71-12.61-74.50-94.08-104.92--
Current Ratio1.471.611.641.452.021.160.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Funds from Operations66.3017.2621.99-169.95-302.24-475.00-94.04-0.02
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital69.02-84.2012.8625.2915.89192.67-24.46-
Cash from Operating Activities135.31-66.9334.84-144.66-286.35-282.33-118.50-0.02
Capital Expenditures-3.03-2.04-1.56-0.58-4.47-0.72-0.690.00
Net Assets From Acquisitions0.000.000.000.00-16.200.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.003.900.00
Purchase or Sale of Investments-39.946.122.12140.60116.05-434.72138.100.00
Purchase of Investments-179.16-205.10-201.24-175.57-369.40-876.25-174.320.00
Sale Or Maturity of Investments139.22211.22203.36316.16485.45441.53312.420.00
Other Uses0.000.000.000.00-0.250.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-42.974.080.56140.0195.13-435.45141.310.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-14.33-53.38-17.36-5.07-4.96290.161.750.00
Repurchase of Common Pref Stock-18.88-55.20-18.26-6.22-6.36-0.150.000.00
Sale of Common Pref Stock4.551.810.901.151.40290.311.750.00
Proceedsfrom Stock Options4.001.810.901.151.40289.921.750.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-30.931.150.00
Change in Long Term Debt0.000.000.000.000.00-30.931.150.00
Issuance of Long Term Debt0.000.000.000.000.000.0020.000.00
Reduction of Long Term Debt0.000.000.000.000.00-30.93-18.850.00
Net Financing Active Other Cash Flow0.000.000.000.0082.42666.16-0.960.02
Other Financing Activities Uses0.000.000.000.000.00-0.09-0.960.00
Cash from Financing Activities-14.33-53.38-17.36-5.0777.46925.391.940.02
Net Change in Cash78.01-116.2418.05-9.72-113.75207.6224.750.00
Free Cash Flow132.28-68.9833.29-145.25-290.81-283.05-119.19-0.02
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow18.16-46.37-----

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Total Cash268.07198.84173.2678.30190.06188.65
Investments244.53244.18244.96241.62205.85200.62
Net Property, Plant & Equipment7.757.236.906.385.495.20
Investment in Unconsolidated Affiliates0.000.000.000.000.000.00
Other Intangible Assets63.7867.3569.9155.9754.7649.17
Total Assets753.68720.33697.73541.01559.66574.99
Insurance Policy Liabilities - Insurance269.10250.89260.42153.25140.46139.66
Total Debt0.000.000.000.000.000.00
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities93.7193.1897.8979.0678.2791.15
Total Liabilities362.81344.07358.30232.31218.73230.81
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity390.87376.26339.43308.70340.93344.18
Total Shareholders Equity390.87376.26339.43308.70340.93344.18
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity390.87376.26339.43308.70340.93344.18
Total Liabilities & Stockholders Equity753.68720.33697.73541.01559.66574.99
Book Value Per Share0.790.760.690.640.700.71
Tangible Book Value Per Share0.780.760.690.630.700.71
Full-Time Employees---724--
Price to Book Ratio6.287.572.773.344.293.99
Return on Assets1.90-2.84-8.89-15.25-9.52-6.74
Return on Equity3.40-5.10-16.86-26.33-16.90-12.59
Return on Invested Capital1.657.448.05-15.98-7.15-3.07
Current Ratio1.551.501.331.471.711.80

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations14.8936.9039.79-25.291.9314.93
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital55.49-11.7168.10-42.8610.17-9.53
Cash from Operating Activities70.3825.19107.89-68.1512.105.41
Capital Expenditures-0.90-0.68-0.85-0.60-0.69-0.57
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-1.980.65-4.21-34.40-4.7336.13
Purchase of Investments-4.96-27.17-40.91-106.11-39.13-26.70
Sale Or Maturity of Investments2.9927.8236.7071.7134.3962.83
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-2.88-0.03-5.07-34.99-5.4235.57
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1.730.42-7.86-8.61-5.27-7.76
Repurchase of Common Pref Stock0.00-1.79-7.89-9.20-5.58-8.47
Sale of Common Pref Stock1.732.200.030.590.300.70
Proceedsfrom Stock Options1.731.650.030.590.300.70
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities1.730.42-7.86-8.61-5.27-7.76
Net Change in Cash69.2325.5794.96-111.751.4133.21
Free Cash Flow69.4824.51107.04-68.7511.414.84
Price to Free Cash Flow18.1638.5117.18---

Revenue breakdown

Hospital & Medical Service Plans2024: 26.25M 2025: 32.58M
United States2024: 26.25M 2025: 32.58M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.61%23.0M410.5M4.20M
2026-10-156.32%25.9M410.5M4.29M
2026-09-305.58%22.9M410.3M4.44M
2026-09-155.71%23.4M410.3M5.14M
2026-08-315.78%23.7M410.0M6.07M
2026-08-146.38%26.1M409.7M6.92M
2026-07-316.96%28.2M405.6M7.34M
2026-07-157.09%28.7M405.6M7.79M
2026-06-305.47%22.2M405.4M7.67M
2026-06-156.13%24.9M405.1M7.32M
2026-05-297.06%28.6M404.9M6.50M
2026-05-159.40%37.4M397.9M6.10M
2026-04-309.88%39.1M395.7M5.79M
2026-04-1510.26%40.6M395.7M5.87M
2026-03-319.88%39.1M396.0M5.94M
2026-03-139.69%38.4M396.0M5.60M
2026-02-279.71%38.5M396.0M5.35M
2026-02-1310.49%41.1M391.7M5.35M
2026-01-3010.01%39.2M391.6M5.97M
2026-01-1510.27%40.2M391.5M6.91M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.504.454.554.5319.19336225.000.996-0.0170.000
call1.003.954.054.0313.18517956.000.994-0.0170.000
call1.503.403.553.559.95628.002.000.991-0.0170.000
call2.002.883.102.889.39315.002.000.982-0.0290.000
call2.502.322.672.398.79411.001.000.976-0.0280.000
call3.001.792.211.957.5158.001.000.969-0.0270.000
call3.501.401.661.495.21477.002.000.959-0.0250.000
call4.000.751.220.894.42559.000.000.942-0.0230.000
call4.500.430.690.572.7411,28020.000.904-0.0190.001
call5.000.080.100.090.6432,2222,1780.527-0.0280.001
call5.500.000.010.010.8452,03173.000.079-0.0120.001
call6.000.000.010.011.4247980.000.048-0.0130.000
call6.500.000.050.011.9101260.000.037-0.0150.000
call7.000.000.010.012.0441200.000.031-0.0110.000
call7.500.000.170.022.7101.000.000.028-0.0160.000
call8.000.000.010.002.6580.000.000.025-0.0120.000
call8.500.000.010.003.4060.000.000.023-0.0170.000
put0.500.000.010.0012.4710.000.00-0.004-0.0120.000
put1.000.000.010.019.9690.001.00-0.007-0.0160.000
put1.500.000.010.009.0790.000.00-0.019-0.0370.000
put2.000.000.170.006.7950.000.00-0.018-0.0290.000
put2.500.000.170.005.2920.000.00-0.024-0.0280.000
put3.000.000.170.004.0580.000.00-0.031-0.0260.000
put3.500.000.030.022.8482980.00-0.067-0.0280.001
put4.000.000.080.142.0514,9560.00-0.058-0.0220.000
put4.500.000.020.011.16012,0637.00-0.096-0.0180.001
put5.000.090.120.120.8551,16910.00-0.473-0.0280.001
put5.500.260.570.621.65215.000.00-0.924-0.0110.001
put6.000.791.261.074.0476.000.00-0.952-0.0130.000
put6.501.291.751.544.7494.000.00-0.963-0.0140.000
put7.001.792.252.095.4172.000.00-0.968-0.0150.000
put7.502.292.752.836.0060.000.00-0.972-0.0150.000
put8.002.793.253.356.5340.000.00-0.975-0.0160.000
put8.503.253.750.007.0110.000.00-0.977-0.0160.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-02SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-10-20144Filing for proposed sale of securities under Rule 144.SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-19144Filing for proposed sale of securities under Rule 144.SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-098-KCurrent report2026-10-08SEC
2026-10-07144Filing for proposed sale of securities under Rule 144.SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-05144Filing for proposed sale of securities under Rule 144.SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-10-013Initial statement of beneficial ownership of securities2026-09-22SEC
2026-10-013Initial statement of beneficial ownership of securities2026-09-22SEC
2026-09-258-K/A2026-09-22SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10002.07M10
2026-09001.62M6
2026-0800486.29K2
2026-07002.50M10
2026-0600156.74K5
2026-05001.45M3
2026-040000
2026-0300390.89K2
2026-020000
2026-010017.18K2
2025-120012.82K1
2025-1100108.78K1

Institutional holders

Manager% owned
BlackRock, Inc.6.67%
VANGUARD CAPITAL MANAGEMENT LLC3.42%
GEODE CAPITAL MANAGEMENT, LLC2.09%
STATE STREET CORP1.93%
Nuveen, LLC1.47%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.05%
VANGUARD PORTFOLIO MANAGEMENT LLC0.85%
NORTHERN TRUST CORP0.72%
DIMENSIONAL FUND ADVISORS LP0.63%
VANGUARD FIDUCIARY TRUST CO0.55%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.46%
iShares Russell 2000 ETF2.05%
VANGUARD EXTENDED MARKET INDEX FUND0.88%
Fidelity Small Cap Index Fund0.87%
iShares Russell 2000 Growth ETF0.74%
VANGUARD RUSSELL 2000 INDEX FUND0.45%
Fidelity Extended Market Index Fund0.37%
Schwab U.S. Small-Cap ETF0.36%
College Retirement Equities Fund - Total Global Stock Account0.35%
Nuveen Quant Small Cap Equity Fund0.34%

OakChart. CLOV. Cached 15 minutes.